- Home
- NHC vs CNTA Comparison
NHC vs CNTA Comparison
Compare NHC & CNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NHC
- CNTA
- Stock Information
- Founded
- NHC 1971
- CNTA 2020
- Country
- NHC United States
- CNTA United Kingdom
- Employees
- NHC N/A
- CNTA N/A
- Industry
- NHC Hospital/Nursing Management
- CNTA Biotechnology: Pharmaceutical Preparations
- Sector
- NHC Health Care
- CNTA Health Care
- Exchange
- NHC Nasdaq
- CNTA Nasdaq
- Market Cap
- NHC 1.4B
- CNTA 1.6B
- IPO Year
- NHC N/A
- CNTA 2021
- Fundamental
- Price
- NHC $102.37
- CNTA $12.87
- Analyst Decision
- NHC
- CNTA Strong Buy
- Analyst Count
- NHC 0
- CNTA 10
- Target Price
- NHC N/A
- CNTA $26.11
- AVG Volume (30 Days)
- NHC 41.7K
- CNTA 659.3K
- Earning Date
- NHC 05-09-2025
- CNTA 05-14-2025
- Dividend Yield
- NHC 2.50%
- CNTA N/A
- EPS Growth
- NHC 31.05
- CNTA N/A
- EPS
- NHC 6.91
- CNTA N/A
- Revenue
- NHC $1,374,458,000.00
- CNTA $15,000,000.00
- Revenue This Year
- NHC N/A
- CNTA N/A
- Revenue Next Year
- NHC N/A
- CNTA N/A
- P/E Ratio
- NHC $14.81
- CNTA N/A
- Revenue Growth
- NHC 18.19
- CNTA 118.88
- 52 Week Low
- NHC $89.14
- CNTA $7.75
- 52 Week High
- NHC $138.49
- CNTA $19.09
- Technical
- Relative Strength Index (RSI)
- NHC 55.75
- CNTA 49.66
- Support Level
- NHC $103.82
- CNTA $12.11
- Resistance Level
- NHC $110.10
- CNTA $13.34
- Average True Range (ATR)
- NHC 2.78
- CNTA 0.82
- MACD
- NHC -0.06
- CNTA 0.07
- Stochastic Oscillator
- NHC 53.29
- CNTA 66.04
About NHC National HealthCare Corporation
National Healthcare Corp Provides long-term care facilities. Its principal business includes the operation of skilled nursing facilities, assisted living facilities, independent living facilities, and home care programs. The company's activities include providing sub-acute and post-acute skilled nursing care, intermediate nursing care, rehabilitative care, memory and Alzheimer's care, senior living services, and home health care services. In addition, the company also provides management services, accounting, and financial services, as well as insurance services to third-party operators of healthcare facilities. Its reportable segments include Inpatient services, and Home care hospice services. Generating, a majority of its revenue from Inpatient services.
About CNTA Centessa Pharmaceuticals plc
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.